Houttuynia cordata targets the beginning stage of herpes simplex virus infection

PLoS One. 2015 Feb 2;10(2):e0115475. doi: 10.1371/journal.pone.0115475. eCollection 2015.

Abstract

Herpes simplex virus (HSV), a common latent virus in humans, causes certain severe diseases. Extensive use of acyclovir (ACV) results in the development of drug-resistant HSV strains, hence, there is an urgent need to develop new drugs to treat HSV infection. Houttuynia cordata (H. cordata), a natural herbal medicine, has been reported to exhibit anti-HSV effects which is partly NF-κB-dependent. However, the molecular mechanisms by which H. cordata inhibits HSV infection are not elucidated thoroughly. Here, we report that H. cordata water extracts (HCWEs) inhibit the infection of HSV-1, HSV-2, and acyclovir-resistant HSV-1 mainly via blocking viral binding and penetration in the beginning of infection. HCWEs also suppress HSV replication. Furthermore, HCWEs attenuate the first-wave of NF-κB activation, which is essential for viral gene expressions. Further analysis of six compounds in HCWEs revealed that quercetin and isoquercitrin inhibit NF-κB activation and additionally, quercetin also has an inhibitory effect on viral entry. These results indicate that HCWEs can inhibit HSV infection through multiple mechanisms and could be a potential lead for development of new drugs for treating HSV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / pharmacology
  • Animals
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology*
  • Cell Line
  • Drug Resistance, Viral / drug effects
  • Gene Expression Regulation, Viral / drug effects
  • Herpesvirus 1, Human / drug effects*
  • Herpesvirus 1, Human / genetics
  • Herpesvirus 1, Human / metabolism
  • Herpesvirus 1, Human / physiology*
  • Herpesvirus 2, Human / drug effects*
  • Herpesvirus 2, Human / genetics
  • Herpesvirus 2, Human / metabolism
  • Herpesvirus 2, Human / physiology*
  • Hot Temperature
  • Houttuynia / chemistry*
  • Humans
  • NF-kappa B / metabolism
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Viral Envelope Proteins / metabolism
  • Virion / drug effects
  • Virion / physiology
  • Virus Internalization / drug effects
  • Virus Replication / drug effects
  • Water / chemistry

Substances

  • Antiviral Agents
  • NF-kappa B
  • Plant Extracts
  • Viral Envelope Proteins
  • glycoprotein D, Human herpesvirus 1
  • Water
  • Acyclovir

Grants and funding

This work was supported by National Research Program for Genomic Medicine of Taiwan (CCMP97-RD-208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.